Kane Biotech Announces First Quarter 2022 Financial

WINNIPEG, Manitoba, May 26, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology...

Related Keywords

United States ,Canada ,James Doub ,Nicole Sendey ,Ray Dupuis ,Gordon Guay ,Marc Edwards ,Gregory Schultz ,Veterinary Oral Health Council ,University Of Texas Medical Branch ,Company Or Kane Biotech ,Kane Biotech Inc ,Dow Development Laboratories ,Animal Health ,Venture Exchange ,Company Dispersin ,Quarter Financial Highlights ,Antimicrobial Hydrogel ,Kane Biotech ,Management Discussion ,Chief Executive ,Chief Scientific Officer ,Corporate Developments ,Helps Control Tarter ,Chief Scientific ,Scientific Advisory Board ,Scientific Advisor ,Assistant Professor ,Maryland School ,Human Virology ,Texas Medical Branch ,Prosthetic Joint Infection ,Thursday May ,Tsx Venture Exchange Kne ,Biotech ,Biotechnologies ,Small Cap ,